Skip to Content

Dengue Fever Vaccine In Sight

Sanofi Pasteur’s drug enters Phase III trials, bringing the first vaccine a step closer.

A dengue fever vaccine created by Sanofi Pasteur has just entered Phase III trials, bringing the company closer to producing something that can prevent the disease than ever before. 

Dengue is not as well-known or widespread as pervasive diseases like malaria, but it infects several million people a year. Although restricted to the tropics, it is growing in geography and today has the potential to infect several billion people, according to the World Health Organization. 

The dengue fever vaccine is the latest in a long line of vaccines targeted at combating mosquito-borne illnesses, and Sanofi is placing a heavy bet that it will work. According to Reuters, Sanofi has invested over $400 million in making a manufacturing facility to create the vaccine in the event that it proves to be effective. Production would start in 2015 if all goes according to plan.

There are four other main competing vaccines but all are more unproven – in Phase I or II instead of Phase III trials like Sanofi’s – and so it would take around half a decade longer for them to come to market.

Creating a Dengue fever vaccine is complicated because there are 4 distinct types, all of which have to be accounted for in a vaccine, for it to be considered effective.

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.